Literature DB >> 1711083

Recurrent utilization of genetic elements in V regions of antinucleic acid antibodies from autoimmune mice.

D Eilat1, R Fischel.   

Abstract

Two IgG anti-DNA and two IgG anti-RNA autoantibodies derived from lupus prone NZB/NZW F1 mice have been analyzed for their Ag fine specificities and for their H and L chain V-region sequences. A remarkable similarity of VH gene sequences with previously sequenced antinucleic acid autoantibodies (Eilat, D., D. M. Webster and A. R. Rees. J. Immunol. 141:1745, 1988) was noted. This finding indicates that a small number of unique VH genes is involved in this autoimmune response and that the sequences of these genes are correlated with the different specificities for the autoantigen. The VK sequences appeared, by computer search, to be selected nonrandomly, but their use was not restricted to autoantibodies. An additional striking feature was evident in the construction of the D region elements, giving rise to CDR3 peptides that can interact with DNA and RNA. These constructs probably include D-D fusion products, which are relatively rare in Ig rearrangements.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711083

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  New data concerning the functional organization of the mammalian cell nucleolus: detection of RNA and rRNA by in situ molecular immunocytochemistry.

Authors:  M Thiry
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

Review 2.  B-cell epitopes of RNA autoantigens.

Authors:  R M Hoet; W J van Venrooij
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

3.  Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Authors:  W A Marasco; J Bagley; C Zani; M Posner; L Cavacini; W A Haseltine; J Sodroski
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.

Authors:  Nathaniel M Green; Krishna-Sulayman Moody; Michelle Debatis; Ann Marshak-Rothstein
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

5.  Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE.

Authors:  Thiago Detanico; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

6.  Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.

Authors:  Kerstin Nündel; Nathaniel M Green; Arthur L Shaffer; Krishna L Moody; Patricia Busto; Dan Eilat; Kensuke Miyake; Michael A Oropallo; Michael P Cancro; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

7.  Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.

Authors:  Xizhang Sun; Alice Wiedeman; Nalini Agrawal; Thomas H Teal; Lena Tanaka; Kelly L Hudkins; Charles E Alpers; Silvia Bolland; Matthew B Buechler; Jessica A Hamerman; Jeffrey A Ledbetter; Denny Liggitt; Keith B Elkon
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

8.  Human organ-specific autoimmune disease. Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ.

Authors:  G D Chazenbalk; S Portolano; D Russo; J S Hutchison; B Rapoport; S McLachlan
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Pollen development in Annona cherimola Mill. (Annonaceae). Implications for the evolution of aggregated pollen.

Authors:  Jorge Lora; Pilar S Testillano; Maria C Risueño; Jose I Hormaza; Maria Herrero
Journal:  BMC Plant Biol       Date:  2009-10-29       Impact factor: 4.215

10.  Centromeric Transcription Regulates Aurora-B Localization and Activation.

Authors:  Michael D Blower
Journal:  Cell Rep       Date:  2016-05-12       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.